Cargando…
Spotlight on therapeutic efficiency of mesenchymal stem cells in viral infections with a focus on COVID-19
The SARS-COV-2 virus has infected the world at a very high rate by causing COVID-19 disease. Nearly 507 million individuals have been infected with this virus, with approximately 1.2% of these patients being dead, indicating that this virus has been out of control in many countries. While researcher...
Autores principales: | Yasamineh, Saman, Kalajahi, Hesam Ghafouri, Yasamineh, Pooneh, Gholizadeh, Omid, Youshanlouei, Hamed Rahmani, Matloub, Saeed Karimi, Mozafari, Masoud, Jokar, Elham, Yazdani, Yalda, Dadashpour, Mehdi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204679/ https://www.ncbi.nlm.nih.gov/pubmed/35715852 http://dx.doi.org/10.1186/s13287-022-02944-7 |
Ejemplares similares
-
An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19
por: Yasamineh, Saman, et al.
Publicado: (2022) -
Recent advances on high-efficiency of microRNAs in different types of lung cancer: a comprehensive review
por: Sadeghi, Mohammad Saleh, et al.
Publicado: (2023) -
Spotlight on the impact of viral infections on Hematopoietic Stem Cells (HSCs) with a focus on COVID-19 effects
por: Nasiri, Kamyar, et al.
Publicado: (2023) -
Therapeutic and diagnostic applications of nanoparticles in the management of COVID-19: a comprehensive overview
por: Gholizadeh, Omid, et al.
Publicado: (2022) -
The potential use of microRNAs as a therapeutic strategy for SARS-CoV-2 infection
por: Hu, Jiulue, et al.
Publicado: (2021)